Brief: Takeda, Insilico Strike AI Drug-Discovery Deal Worth Up To $600 Million - WSJ
BRIEF-Takeda, Insilico Strike AI Drug-Discovery Deal Worth Up To $600 Million - WSJ July 1 (Reuters) -
TAKEDA, INSILICO STRIKE AI DRUG-DISCOVERY DEAL WORTH UP TO $600 MILLION - WSJ
TAKEDA WILL BE GRANTED EXCLUSIVE WORLDWIDE RIGHTS UNDER INSILICO DEAL TO DEVELOP, MANUFACTURE AND COMMERCIALIZE NEW DRUGS - WSJ
Source text: [ID: https://tinyurl.com/23bhpefm]
Further company coverage: 3696.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Takeda Pharmaceutical
See all newsFactbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics tumbles below IPO price
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom (updated)